Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Animal Growth Promoters and Performance Enhancers Market Size & Share 2026-2035
Report ID: GMI5893
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Animal Growth Promoters and Performance Enhancers Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Animal Growth Promoters and Performance Enhancers Market Size
The animal growth promoters and performance enhancers market was valued at USD 9.50 billion in 2025, is valued at USD 10.02 billion in 2026, and is projected to grow at a 5.6% CAGR (2026–2035) to reach USD 16.35 billion by 2035. The market covers additives and promoter systems used in commercial livestock, poultry, aquaculture, and other animal-production settings to support feed efficiency, weight gain, gut health, and production consistency.
Animal Growth Promoters and Performance Enhancers Market Key Takeaways
Market Leader: Adisseo led with over 19.5% market share in 2025.
Leading Players: Top 5 players in this market include Adisseo, Evonik Animal Nutrition, DSM-Firmenich Animal Nutrition & Health, Cargill Animal Nutrition, BASF Animal Nutrition, which collectively held a market share of 66.7% in 2025.
The market's expansion reflects a shift in the economics of animal production rather than simply higher additive usage. Larger, more integrated production systems require dependable feed-conversion outcomes, while restrictions on routine antimicrobial use are redirecting formulation demand toward enzymes, probiotics, organic acids, and phytogenic products. This changes the revenue mix in favor of differentiated, evidence-backed solutions while maintaining demand for cost-effective conventional inputs where permitted.
GMI Analyst View
Based on our assessment of industry demand patterns, the market expanded at a consistent 5.0% annual rate during the 2022–2025 historic period. We view that performance as evidence that production intensification and protein-demand fundamentals can sustain aggregate demand despite regulatory tightening and cyclical feed-input volatility.
Animal Growth Promoters and Performance Enhancers Market Trends, Growth Drivers & GMI Forecast Outlook
The market is being shaped by two reinforcing forces: commercial animal production is broadening the addressable feed base, while stewardship requirements are accelerating a transition toward performance additives that can demonstrate efficacy without reliance on antibiotic growth promotion. The pace of growth will depend on how quickly compliant alternatives can be approved, scaled, and adopted across species and geographies.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Global animal-protein consumption is becoming more dependent on commercial production systems that must manage feed efficiency, animal health, and output consistency at scale. Per-capita calorie intake from livestock and fish products is projected to increase 6% globally over the next decade [1]Food and Agriculture Organization of the United Nations and Organisation for Economic Co-operation and Development. "OECD-FAO Agricultural Outlook 2025-2034: Emerging Economies Will Drive Growth in Animal-Source Food Consumption and Production." fao.org. That demand does not translate uniformly across additive classes: it increases baseline feed-additive use, while the operational need to improve yields favors products with measurable species-specific performance benefits.
The regulatory transition creates a separate source of demand by changing the preferred composition of additive programs. As producers replace restricted antimicrobial growth-promoter practices, suppliers with validated enzyme, microbial, acidifier, and botanical platforms are positioned to participate in reformulation budgets. The opportunity is strongest where suppliers can combine efficacy documentation, manufacturing consistency, and registration support for multiple national markets.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The decline in animal antimicrobial use is commercially consequential because the affected products have historically been embedded in routine production practices. WOAH reports that 71% of survey participants have phased out antimicrobial use for growth promotion [2]World Organisation for Animal Health. "Less Antimicrobial Use in Animals: A Win for Everyone." woah.org. The remaining demand is increasingly exposed to customer specifications, retailer standards, and national stewardship programs, which can reduce the addressable market before a formal prohibition takes effect.
Approval complexity also favors companies with established regulatory, toxicology, and species-trial capabilities. It can protect approved premium products from immediate price competition, but it may delay the commercial availability of alternatives in markets where reformulation demand is rising quickly. For customers, the constraint is not merely product availability; it is the ability to source a consistently performing, locally compliant formulation at commercial scale.
GMI Analyst View
We expect the forecast to be shaped less by a single demand shock than by a continuing mix transition. Suppliers that can document performance under antibiotic-restricted production conditions should gain strategic relevance, while companies dependent on legacy promoter categories will face a more selective and regulation-sensitive addressable market.
Animal Growth Promoters and Performance Enhancers Market Segment Analysis
By Product Type
Feed Enzymes accounted for 16.0% of the animal growth promoters and performance enhancers market in 2025 and are projected to generate USD 3.10 billion in revenue by 2035. Their position is supported by their role in improving nutrient availability and feed economics across poultry and swine systems, with further adoption potential in aquaculture and ruminant applications as multi-enzyme programs become more tailored to species-specific diets.
Antibiotic Growth Promoters are projected to represent 11.1% of the market by 2035, compared with revenue of USD 1.42 billion in 2025. The segment remains relevant where veterinary and feed regulations permit its use, but its strategic direction is toward a narrower, more regulated specialty market as producers transition to alternatives that meet antibiotic-reduction and residue-management requirements.
Probiotic & Prebiotic additives held a 14.0% market share in 2025 and are forecast to expand at an 8.1% CAGR (2026–2035). Demand is tied to their use in gut-health programs intended to support resilience, feed utilization, and production consistency, particularly in poultry, swine, and aquaculture systems operating with reduced antibiotic inputs.
Organic Acids are projected to reach USD 2.00 billion by 2035 and are expected to grow at a 5.8% CAGR (2026–2035). Their commercial appeal comes from a combination of preservation, acidification, and gut-health functions, allowing them to remain a practical component of feed programs across cost-sensitive and premium production systems.
Phytogenic / Botanical Extracts generated USD 950 million in revenue in 2025 and are projected to account for 13.4% of the market by 2035. Essential oils, tannins, saponins, and related botanical systems are gaining commercial traction as formulators seek natural-positioned alternatives that can be differentiated through mode of action, traceability, and compatibility with antibiotic-free production claims.
Hormonal Growth Promoters are projected to generate USD 900 million in revenue by 2035, while accounting for 8.0% of market revenue in 2025. Their outlook is constrained by uneven regulatory acceptance and market-access considerations, particularly for producers supplying export channels that apply restrictive standards to hormone use.
Others accounted for 25.0% of market revenue in 2025. This category reflects the breadth of specialty performance inputs, including mineral, vitamin, amino-acid, eubiotic, and functional formulations that remain fragmented across species, production systems, and local feed practices.
By Animal Type
Poultry accounted for 35.0% of market revenue in 2025 and is projected to generate USD 5.39 billion by 2035. Short production cycles, highly commercialized feeding practices, and the operational value of small improvements in feed conversion make poultry the principal volume anchor for enzyme, probiotic, organic-acid, and phytogenic demand.
Swine / Porcine operations generated USD 2.09 billion in revenue in 2025 and are projected to account for 20.0% of the market by 2035. The segment's additive requirements are shaped by herd-health management, post-disease recovery dynamics, feed-cost control, and a growing preference for gut-health solutions that can support performance under reduced-antibiotic protocols.
Livestock / Ruminants generated USD 1.90 billion in revenue in 2025 and are projected to grow at a 5.0% CAGR (2026–2035). Demand is differentiated by rumen physiology and production objectives, supporting specialized use of rumen modifiers, direct-fed microbials, methionine products, and eubiotics in beef and dairy systems.
Aquaculture is projected to reach USD 2.78 billion by 2035 and is forecast to grow at a 7.6% CAGR (2026–2035). Higher-density fish and shrimp production increases the commercial importance of feed conversion, mortality management, and water-quality-aware nutrition, creating a favorable setting for specialized enzyme, organic-acid, and microbial products.
Equine applications held a 4.0% market share in 2025 and are projected to represent 3.5% by 2035. The category remains supported by performance nutrition in racing, sport, and working-horse settings, although its relative market weight is moderated by faster expansion in commercial livestock and aquaculture.
Other Animals are projected to account for 7.5% of the market by 2035 and are forecast to expand at a 9.9% CAGR (2026–2035). Growth reflects rising use of tailored additive programs in specialty livestock and other emerging commercial species, where feed practices are becoming more formalized and performance management is gaining importance.
By Source
Natural additives accounted for 55.0% of market revenue in 2025 and are projected to reach 60.0% by 2035. Their share gains are being driven by regulatory pressure on conventional antimicrobial practices, demand for residue-conscious production, and suppliers' ability to differentiate microbial, botanical, and fermentation-based formulations.
Synthetic additives represented 45.0% of market revenue in 2025 and are projected to account for 40.0% by 2035. They remain commercially important in price-sensitive feed programs and in markets where established synthetic amino acids, preservation products, and permitted hormonal inputs retain a cost or performance advantage.
GMI Analyst View
We see the strongest segment-level opportunity in formulations that combine demonstrable biological performance with practical integration into commercial feed systems. The most durable suppliers will not necessarily be those with the broadest catalogues, but those that can translate species-specific efficacy, regulatory documentation, and formulation reliability into repeatable customer outcomes.
Animal Growth Promoters and Performance Enhancers Market Regional Analysis
North America Animal Growth Promoters and Performance Enhancers Market Analysis
North America accounted for 32.0% of the animal growth promoters and performance enhancers market in 2025 and is projected to generate USD 4.90 billion by 2035. Advanced poultry, swine, dairy, and feedlot systems support high additive penetration, while stewardship programs and customer-facing antibiotic-reduction commitments favor enzyme, probiotic, and other alternative performance platforms.
U.S.
The U.S. generated USD 2.58 billion in revenue in 2025 and is projected to reach USD 4.16 billion by 2035. Its highly integrated protein supply chains, specialist distribution networks, and broad manufacturing base support adoption of premium additives, particularly where producers seek to align production economics with antibiotic-reduction standards.
Canada
Canada accounted for 15.0% of North American market revenue in 2025 and is projected to generate USD 735 million by 2035. Demand is concentrated in poultry, swine, and dairy operations, while cross-border supply integration provides access to established enzyme, probiotic, and specialty-additive portfolios.
Europe Animal Growth Promoters and Performance Enhancers Market Analysis
Europe is projected to account for 21.2% of the market by 2035 and generated USD 2.28 billion in revenue in 2025. The region's long-established restrictions on antibiotic growth promotion have created a mature market for biological, enzyme-based, and specialty nutritional approaches, with growth more dependent on product innovation and premiumization than on basic portfolio conversion.
Germany
Germany generated USD 502 million in revenue in 2025 and is projected to reach USD 763 million by 2035. Its technology-intensive pork and poultry production base, together with access to regional nutrition and additive manufacturing clusters, supports a high-value demand profile.
France
France accounted for 15.0% of European market revenue in 2025 and is projected to generate USD 520 million by 2035. Poultry, pork, and dairy operations sustain demand for feed enzymes, organic acids, and specialty supplements, with growth centered on optimizing established production programs.
UK
The UK is projected to generate USD 485 million by 2035 and accounted for 14.0% of European market revenue in 2025. Regulatory divergence from the EU can affect authorization timing, but commercial demand remains closely connected to continental supply chains and to the country's focus on welfare- and sustainability-oriented protein production.
Italy
Italy remains an important European market through its poultry, pork, and specialty dairy sectors. Demand is supported by use of organic acids, mineral supplements, and production-specific nutrition programs within the EU feed-additive framework.
Asia Pacific Animal Growth Promoters and Performance Enhancers Market Analysis
Asia Pacific accounted for 30.0% of market revenue in 2025 and is projected to grow at a 6.9% CAGR (2026–2035). Expanding commercial production of poultry, pork, fish, shrimp, and dairy products is increasing demand for feed-efficiency and gut-health solutions, although country-level opportunities vary significantly by regulatory regime, production structure, and species mix.
China
China accounted for 40.0% of Asia Pacific market revenue in 2025 and is projected to generate USD 2.22 billion by 2035. Its transition away from non-medical antibiotic growth promoters, combined with the ongoing evolution of commercial swine production, is increasing the importance of enzymes, probiotics, and organic-acid programs.
India
India generated USD 570 million in revenue in 2025 and is projected to reach USD 1.11 billion by 2035. Poultry and aquaculture are central growth channels, while increasing use of precision nutrition by commercial integrators creates scope for broader adoption of feed enzymes and microbial solutions.
Japan
Japan accounted for 12.0% of Asia Pacific market revenue in 2025 and is projected to generate USD 667 million by 2035. Mature poultry, pork, and dairy systems favor technically sophisticated feed-enzyme and specialty-probiotic programs designed for tightly managed production environments.
Australia
Australia generated USD 228 million in revenue in 2025 and is projected to reach USD 445 million by 2035. Demand is anchored in beef feedlots and commercial poultry production, with export-oriented protein supply chains supporting interest in natural and performance-validated additive systems.
Latin America Animal Growth Promoters and Performance Enhancers Market Analysis
Latin America is projected to generate USD 1.63 billion by 2035 and is forecast to grow at a 6.7% CAGR (2026–2035). The region's large integrated poultry, beef, and swine industries provide a strong commercial base for additives that improve feed conversion and production resilience, while export requirements are raising interest in antibiotic-free and natural-positioned formulations.
Brazil
Brazil accounted for 50.0% of Latin American market revenue in 2025 and is projected to generate USD 818 million by 2035. Its large poultry-export and beef-production sectors create substantial demand for additives linked to feed efficiency, immune support, and compliance with destination-market requirements.
Mexico
Mexico generated USD 171 million in revenue in 2025 and is projected to reach USD 327 million by 2035. Commercial swine and broiler operations are the principal demand centers, with modernization among major integrators supporting uptake of more structured additive programs.
Middle East & Africa Animal Growth Promoters and Performance Enhancers Market Analysis
Middle East & Africa accounted for 5.0% of market revenue in 2025 and is projected to generate USD 795 million by 2035. Food-security investment, poultry-sector expansion, commercial dairy development, and growing aquaculture activity support demand, although regulatory maturity and purchasing power vary substantially across the region.
Saudi Arabia
Saudi Arabia accounted for 20.0% of Middle East & Africa market revenue in 2025 and is projected to generate USD 159 million by 2035. State-backed investment in poultry and dairy capacity, along with vertically integrated production models, supports demand for reliable performance and feed-efficiency solutions.
South Africa
South Africa generated USD 71 million in revenue in 2025 and is projected to reach USD 119 million by 2035. Its developed feed-manufacturing and commercial poultry sectors also support its role as a distribution and application hub for southern African markets.
GMI Analyst View
We believe regional strategy will require more than allocating resources to the fastest-growing markets. Commercial success will depend on matching portfolios to each geography's regulatory pathway, feed-manufacturing sophistication, species concentration, and customer ability to pay for validated performance. Asia Pacific offers the broadest growth runway, while selective Middle Eastern and African markets warrant attention where modern production capacity is scaling.
Animal Growth Promoters and Performance Enhancers Market Share & Competitive Landscape
The animal growth promoters and performance enhancers market share structure is moderately concentrated, with the top five suppliers holding a combined 66.7% market share in 2025. Scale in amino-acid production, enzyme development, formulation, regulatory support, and global distribution gives leading companies material advantages, while regional specialists remain competitive through application expertise, proprietary strains, and localized customer service.
Adisseo (Bluestar Adisseo Company) held a 19.5% market share in 2025. Its competitive position is supported by methionine capabilities and a growing specialty-additives platform that spans eubiotics, organic-acid, and phytogenic-oriented applications.
Evonik Industries AG accounted for 15.3% of market revenue in 2025. The company combines a strong amino-acid franchise with investments in probiotic and botanical offerings, positioning it to participate in both conventional feed efficiency programs and the shift toward higher-value specialty nutrition.
DSM-Firmenich Animal Nutrition & Health held a 13.0% market share in 2025. Its broad animal-nutrition portfolio spans vitamins, amino acids, gut-health products, and enzymes; the planned sale of its Feed Enzyme Alliance stake to Novonesis signals a focused portfolio restructuring in the enzyme segment [5]dsm-firmenich. "dsm-firmenich to Sell Stake in Feed Enzymes Alliance to Its Partner Novonesis for €1.5 Billion." our-company.dsm-firmenich.com.
Cargill, Incorporated benefits from its integration across feed manufacturing, agricultural commodities, and protein production. This footprint supports customer access and formulation capabilities that can be difficult for pure-play additive suppliers to replicate.
Phibro Animal Health Corporation has expanded its presence in medicated feed additives through the acquisition of Zoetis's portfolio and associated assets, reinforcing its position as an independent supplier in a category undergoing structural consolidation [4]Phibro Animal Health Corporation. "Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance." investors.pahc.com.
Elanco Animal Health Incorporated participates through ionophore and anticoccidial products serving beef and poultry operations. Its position is closely tied to regulated animal-health applications and established production protocols.
Boehringer Ingelheim Animal Health competes through gut-health and mycotoxin-management offerings alongside its wider animal-health portfolio. Its ability to connect feed-related solutions with broader veterinary relationships is relevant in complex commercial production systems.
BASF SE (Animal Nutrition) participates across vitamins, pigments, enzymes, amino acids, and specialty additives. Manufacturing depth and technical capabilities support its role in mainstream and premium feed-nutrition channels.
Kemin Industries, Inc. is positioned around gut-health management, antioxidants, mold inhibition, and natural preservation. Its specialist orientation is particularly relevant where customers seek application-specific support rather than broad commodity supply.
Alltech, Inc. competes through fermentation-based technologies, including yeast-derived and prebiotic solutions. Proprietary strain and fermentation capabilities provide differentiation in natural biological additive applications.
Novus International, Inc. focuses on methionine and organic trace-mineral solutions for performance nutrition. The company's value proposition is closely linked to measurable feed-efficiency outcomes in monogastric production systems.
Lallemand Animal Nutrition supplies yeast, fermentation derivatives, and probiotic bacteria across livestock, poultry, and aquaculture. Its specialist microbial platform is well aligned with demand for alternatives that support gut health and production resilience.
Recent Industry Developments
Novonesis completed its acquisition of dsm-firmenich's Feed Enzyme Alliance stake in June 2025. The closing transferred sales and distribution responsibilities for the alliance's enzyme portfolio to Novonesis, giving the company full control of the associated animal-biosolutions value chain [6]Novonesis. "Deal to Acquire dsm-firmenich's Share of the Feed Enzyme Alliance Is Completed, Supporting Novonesis' Growth Strategy." novonesis.com. The transaction follows dsm-firmenich's earlier sale announcement and is likely to sharpen competitive attention on feed-enzyme development, manufacturing, and commercial delivery [5]dsm-firmenich. "dsm-firmenich to Sell Stake in Feed Enzymes Alliance to Its Partner Novonesis for €1.5 Billion." our-company.dsm-firmenich.com.
Phibro Animal Health Corporation completed its acquisition of Zoetis's medicated feed additive portfolio in October 2024. The transaction added a broader set of medicated feed-additive products and manufacturing assets to Phibro's operations, strengthening its global presence in the category [4]Phibro Animal Health Corporation. "Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance." investors.pahc.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →